The Lodge analyst said 0.30 before and up to 0.50 afterwards. At 0.10 a market cap of 83 millions is just nonsenses for a successful biotech with positive clinical Trial readout.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025